MedTrace Logo

Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Knee Osteoarthritis

NCT05398874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-09-02

No results posted yet for this study

Summary

To assess the efficacy and safety of the Ginkgo biloba extract in patients with Knee OA.

Conditions

Interventions

COMBINATION_PRODUCT

Ginkgo biloba extract + standard treatment( paracetamol+Diclofenac100mg SR)

120 mg leaf extract , twice daily in addition to Diclofenac 100 mg Once daily + paracetamol 1g Twice daily

COMBINATION_PRODUCT

placebo in addition to the standard treatment

placebo in addition to the standard treatment

Sponsors & Collaborators

  • Kufa University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-06-01
Completion
2022-08-01

Countries

  • Iraq

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05398874 on ClinicalTrials.gov